On January 10, 2018, Nature published research co-authored by 2014 Julie Martin Mid-Career Award in Aging Research recipient, Satchidananda Panda, Ph.D.
In “Pharmacological activation of REV-ERBs is lethal in cancer and oncogene- induced senescence,” Dr. Panda with other Salk Institute researchers discovered how to curb the growth of cancer cells by blocking the cells’ access to certain nutrients.
In a related release, Panda states: "When we block access to these resources, cancer cells starve to death but normal cells are already used to this constraint so they're not affected.”
The original research is available by subscription only, but the release can be read here.
For more on Dr. Panda’s AFAR-funded research, read his Grantee Spotlight Interview here.
---------------------------------
Satchidananda Panda is a Professor of the Regulator Biology Laboratory at the Salk Institute for Biological Studies.
